Adult epilepsy

Lancet

Volumn 367, Issue 9516, 2006, Pages 1087-1100

  Duncan, John S ^a   Sander, Josemir W ^a   Sisodiya, Sanjay M ^a   Walker, Matthew C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PREGABALIN; PRIMIDONE; SULTIAME; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABSENCE OF SIDE EFFECTS; AGRANULOCYTOSIS; APLASTIC ANEMIA; BLOOD DYSCRASIA; BRAIN DEPTH STIMULATION; BRAIN DISEASE; CLINICAL PRACTICE; COGNITIVE DEFECT; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; DUPUYTREN CONTRACTURE; EPILEPSY; FOCAL EPILEPSY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; HYPONATREMIA; INCIDENCE; LIVER FAILURE; LIVER TOXICITY; LUPUS LIKE SYNDROME; MONOGENIC DISORDER; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEPHROLITHIASIS; NEUROIMAGING; NEUROPHYSIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMALACIA; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHARMACOGENETICS; PRIORITY JOURNAL; PSEUDOLYMPHOMA; RASH; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; STRUCTURE ANALYSIS; TERATOGENICITY; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; VISUAL FIELD DEFECT; WEIGHT GAIN; WEIGHT REDUCTION; ADULT; AGED; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; INFANT;

ADULT; AGED; ANTICONVULSANTS; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; INCIDENCE; INFANT; PHARMACOGENETICS;

EID: 33645745372     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68477-8     Document Type: Review

References (156)

1. Engel Jr. J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 (2001) 796-803
2. NICE. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. http://www.nice.org.uk/page.aspx?o=227586 (accessed Mar 16, 2006)
3. De Boer H. "Out of the shadows": a global campaign against epilepsy. Epilepsia 43 suppl 6 (2002) 7-8
4. Diop A., De Boer H., Mandlhate C., et al. The global campaign against epilepsy in Africa. Acta Trop 87 (2003) 149-159
5. Scott R., Lhatoo S., and Sander J. The treatment of epilepsy in developing countries: where do we go from here?. Bull World Health Organ 79 (2001) 344-351
6. Meinardi H., Scott R., Reis R., et al. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 42 (2001) 136-149
7. MacDonald B., Cockerell O., Sander J., et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123 (2000) 665-676
8. Sander J. The epidemiology of epilepsy revisited. Curr Opin Neurol 16 (2003) 165-170
9. Forsgren L., Beghi E., Oun A., et al. The epidemiology of epilepsy in Europe-a systematic review. Eur J Neurol 12 (2005) 245-253
10. Heaney D., MacDonald B., Everitt A., et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 325 (2002) 1013-1016
11. Sander J. Infectious agents and epilepsy. In: Knobler S., O'Connor S., Lemon S., and Najafi M. (Eds). The infectious etiology of chronic diseases: defining the relationship, enhancing the research and mitigating the effects (2004), The National Academies Press, Washington 93-99
12. Everitt A., and Sander J. Incidence of epilepsy is now higher in elderly people than children. BMJ 316 (1998) 780
13. Sander J., and Bell G. Reducing mortality: an important aim of epilepsy management. J Neurol Neurosurg Psychiatry 75 (2004) 349-351
14. Morgan C., and Kerr M. Epilepsy and mortality: a record linkage study in a U.K. population. Epilepsia 43 (2002) 1251-1255
15. Granger N., Convers P., Beauchet O., et al. First epileptic seizure in the elderly: electroclinical and etiological data in 341 patients. Rev Neurol (Paris) 158 (2002) 1088-1095
16. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2 (2002) 751-762
17. Garcia H., Gonzalez A., Evans C., Gilman R., and for the Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 362 (2003) 547-556
18. Maguire J. Tapeworms and seizures-treatment and prevention. N Engl J Med 350 (2004) 215-217
19. Carter J., Neville B., White S., et al. Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia 45 (2004) 978-981
20. Medina M., Duron R., Martinez L., et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia 46 (2005) 124-131
21. Nicoletti A., Bartoloni A., Reggio A., et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 58 (2002) 1256-1261
22. Boussinesq M., Pion S., Demanga N., et al. Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon. Trans R Soc Trop Med Hyg 96 (2002) 537-541
23. MacDonald B., Johnson A., Goodridge D., et al. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 48 (2000) 833-841
24. Brodie M., and Kwan P. Staged approach to epilepsy management. Neurology 58 suppl 5 (2002) S2-S8
25. Dlugos D., Sammel M., Strom B., et al. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 57 (2001) 2259-2264
26. Kwan P., and Sander J. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 75 (2004) 1376-1381
27. Smith D., Defalla B., and Chadwick D. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM 92 (1999) 15-23
28. Gaitatzis A., Carroll K., Majeed A., et al. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45 (2004) 1613-1622
29. Lhatoo S., Johnson A., Goodridge D., et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 49 (2001) 336-344
30. Gaitatzis A., Johnson A., Chadwick D., et al. Life expectancy in people with newly diagnosed epilepsy. Brain 127 (2004) 2427-2432
31. Gaitatzis A., and Sander J. The mortality of epilepsy revisited. Epileptic Disord 6 (2004) 3-13
32. Hanna J., Black M., Sander J., et al. Death in the shadows: the national sentinel clinical audit into epilepsy death (2002), National Institute for Clinical Excellence, London
33. Nilsson L., Farahmand B., Persson P., Thiblin I., and Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353 (1999) 888-893
34. Sperling M., Feldman H., Kinman J., et al. Seizure control and mortality in epilepsy. Ann Neurol 46 (1999) 45-50
35. Opeskin K., and Berkovic S. Risk factors for sudden unexpected death in epilepsy: a controlled prospective study based on coroners cases. Seizure 12 (2003) 456-464
36. Langan Y., Nashef L., and Sander J. Case-control study of SUDEP. Neurology 64 (2005) 1131-1133
37. Rugg-Gunn F., Simister R., Squirrell M., Holdright D., and Duncan J. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet 364 (2004) 2212-2219
38. Fisher R., van Emde B., Blume W., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46 (2005) 470-472
39. de Curtis M., and Avanzini G. Interictal spikes in focal epileptogenesis. Prog Neurobiol 63 (2001) 541-567
40. Ward L. Synchronous neural oscillations and cognitive processes. Trends Cogn Sci 7 (2003) 553-559
41. Jefferys J. Models and mechanisms of experimental epilepsies. Epilepsia 44 suppl 12 (2003) 44-50
42. Litt B., and Echauz J. Prediction of epileptic seizures. Lancet Neurol 1 (2002) 22-30
43. McCormick D., and Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 63 (2001) 815-846
44. Meeren H., van Luijtelaar G., Lopes D., et al. Evolving concepts on the pathophysiology of absence seizures: the cortical focus theory. Arch Neurol 62 (2005) 371-376
45. Woermann F., Free S., Koepp M., et al. Abnormal cerebral structure in juvenile myoclonic epilepsy demonstrated with voxel-based analysis of MRI. Brain 122 (1999) 2101-2108
46. Guerrini R. Genetic malformations of the cerebral cortex and epilepsy. Epilepsia 46 suppl 1 (2005) 32-37
47. Gutierrez-Delicado E., and Serratosa J. Genetics of the epilepsies. Curr Opin Neurol 17 (2004) 147-153
48. Cossette P., Liu L., Brisebois K., et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 31 (2002) 184-189
49. Suzuki T., Delgado-Escueta A., Aguan K., et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 36 (2004) 842-849
50. Kanai K., Hirose S., Oguni H., et al. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology 63 (2004) 329-334
51. Mulley J., Scheffer I., Petrou S., et al. SCN1A mutations and epilepsy. Hum Mutat 25 (2005) 535-542
52. Baulac S., Huberfeld G., Gourfinkel-An I., et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 28 (2001) 46-48
53. Bonanni P., Malcarne M., Moro F., et al. Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations. Epilepsia 45 (2004) 149-158
54. Anderson E., Berkovic S., Dulac O., et al. ILAE genetics commission conference report: molecular analysis of complex genetic epilepsies. Epilepsia 43 (2002) 1262-1267
55. Marini C., Scheffer I., Crossland K., et al. Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia 45 (2004) 467-478
56. Greenberg D., Cayanis E., Strug L., et al. Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. Am J Hum Genet 76 (2005) 139-146
57. Cavalleri G., Lynch J., Depondt C., et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here?. Brain 128 (2005) 1832-1840
58. Tan N., Mulley J., and Berkovic S. Genetic association studies in epilepsy: "the truth is out there". Epilepsia 45 (2004) 1429-1442
59. Ottman R. Analysis of genetically complex epilepsies. Epilepsia 46 suppl 10 (2005) 7-14
60. Zaidi A., Clough P., Cooper P., et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 36 (2000) 181-184
61. Cascino G. Video-EEG monitoring in adults. Epilepsia 43 suppl 3 (2002) 80-93
62. Von Oertzen J., Urbach H., Jungbluth S., et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry 73 (2002) 643-647
63. Duncan J. Neuroimaging for epilepsy: quality and not just quantity is important. J Neurol Neurosurg Psychiatry 73 (2002) 612-613
64. Recommendations for neuroimaging of patients with epilepsy. Commission on Neuroimaging of the International League Against Epilepsy. Epilepsia 38 (1997) 1255-1256
65. Berkovic S., Duncan J., Barkovich A., et al. ILAE neuroimaging commision recommendations for neuroimaging of persons with refractory epilepsy. Epilepsia 39 (1998) 1375-1376
66. Rugg-Gunn F., Eriksson S., Symms M., et al. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain 124 (2001) 627-636
67. Rugg-Gunn F., Eriksson S., Boulby P., et al. Magnetization transfer imaging in focal epilepsy. Neurology 60 (2003) 1638-1645
68. Briellmann R., Jackson G., Pell G., et al. Structural abnormalities remote from the seizure focus: a study using T2 relaxometry at 3 T. Neurology 63 (2004) 2303-2308
69. Rugg-Gunn F., Boulby P., Symms M., et al. Whole-brain T2 mapping demonstrates occult abnormalities in focal epilepsy. Neurology 64 (2005) 318-325
70. Guye M., Parker G., Symms M., et al. Combined functional MRI and tractography to demonstrate the connectivity of the human primary motor cortex in vivo. Neuroimage 19 (2003) 1349-1360
71. Powell H., Parker G., Alexander D., et al. MR tractography predicts visual field defects following temporal lobe resection. Neurology 65 (2005) 596-599
72. Antel S., Collins D., Bernasconi N., et al. Automated detection of focal cortical dysplasia lesions using computational models of their MRI characteristics and texture analysis. Neuroimage 19 (2003) 1748-1759
73. Keller S., Wilke M., Wieshmann U., et al. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 23 (2004) 860-868
74. Liu R., Lemieux L., Bell G., et al. Progressive neocortical damage in epilepsy. Ann Neurol 53 (2003) 312-324
75. Briellmann R., Berkovic S., Syngeniotis A., et al. Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol 51 (2002) 641-644
76. Fuerst D., Shah J., Shah A., et al. Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol 53 (2003) 413-416
77. Adcock J., Wise R., Oxbury J., et al. Quantitative fMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy. Neuroimage 18 (2003) 423-438
78. Liegeois F., Connelly A., Cross J., et al. Language reorganization in children with early-onset lesions of the left hemisphere: an fMRI study. Brain 127 (2004) 1229-1236
79. Sabsevitz D., Swanson S., Hammeke T., et al. Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery. Neurology 60 (2003) 1788-1792
80. Noppeney U., Price C., Duncan J., et al. Reading skills after left anterior temporal lobe resection: an fMRI study. Brain 128 (2005) 1377-1385
81. Woermann F., Jokeit H., Luerding R., et al. Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology 61 (2003) 699-701
82. Golby A., Poldrack R., Illes J., et al. Memory lateralization in medial temporal lobe epilepsy assessed by functional MRI. Epilepsia 43 (2002) 855-863
83. Richardson M., Strange B., Duncan J., et al. Preserved verbal memory function in left medial temporal pathology involves reorganisation of function to right medial temporal lobe. Neuroimage 20 suppl 1 (2003) S112-S119
84. Richardson M., Strange B., Thompson P., et al. Pre-operative verbal memory fMRI predicts post-operative memory decline after left temporal lobe resection. Brain 127 (2004) 2419-2426
85. Rabin M., Narayan V., Kimberg D., et al. Functional MRI predicts post-surgical memory following temporal lobectomy. Brain 127 (2004) 2286-2298
86. Federico P., Archer J., Abbott D., et al. Cortical/subcortical BOLD changes associated with epileptic discharges: an EEG-fMRI study at 3 T. Neurology 64 (2005) 1125-1130
87. Kobayashi E., Bagshaw A., Jansen A., et al. Intrinsic epileptogenicity in polymicrogyric cortex suggested by EEG-fMRI BOLD responses. Neurology 64 (2005) 1263-1266
88. Cascino G., Buchhalter J., Mullan B., et al. Ictal SPECT in nonlesional extratemporal epilepsy. Epilepsia 45 suppl 4 (2004) 32-34
89. Van Paesschen W., Dupont P., Van Driel G., et al. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain 126 (2003) 1103-1111
90. Chassoux F., Semah F., Bouilleret V., et al. Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study. Brain 127 (2004) 164-174
91. Hammers A., Koepp M., Richardson M., et al. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain 126 (2003) 1300-1318
92. Juhasz C., Chugani D., Muzik O., et al. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60 (2003) 960-968
93. Merlet I., Ryvlin P., Costes N., et al. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage 22 (2004) 886-896
94. Sheth R., Stafstrom C., and Hsu D. Nonpharmacological treatment options for epilepsy. Semin Pediatr Neurol 12 (2005) 106-113
95. Kossoff E. More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol 3 (2004) 415-420
96. Sander J. The use of antiepileptic drugs-principles and practice. Epilepsia 45 suppl 6 (2004) 28-34
97. Birbeck G., Hays R., Cui X., et al. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 43 (2002) 535-538
98. Walker M., and Fisher A. Mechanisms of antiepileptic drugs. In: Shorvon S., Fish D., Dodson E., and Perucca E. (Eds). The treatment of epilepsy (2004), Blackwells, Oxford 96-119
99. Lynch B., Lambeng N., Nocka K., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101 (2004) 9861-9866
100. Poolos N., Migliore M., and Johnston D. Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nat Neurosci 5 (2002) 767-774
101. Surges R., Freiman T., and Feuerstein T. Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells. Epilepsia 44 (2003) 150-156
102. Walker M., White H., and Sander J. Disease modification in partial epilepsy. Brain 125 (2002) 1937-1950
103. McCorry D., Chadwick D., and Marson A. Current drug treatment of epilepsy in adults. Lancet Neurol 3 (2004) 729-735
104. Marson A., Jacoby A., Johnson A., et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 365 (2005) 2007-2013
105. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 3 (2004) 618-621
106. Vazquez B. Monotherapy in epilepsy: role of the newer antiepileptic drugs. Arch Neurol 61 (2004) 1361-1365
107. LaRoche S., and Helmers S. The new antiepileptic drugs: clinical applications. JAMA 291 (2004) 615-620
108. Rowan A., Ramsay R., Collins J., et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64 (2005) 1868-1873
109. University of Liverpool. SANAD. http://www.liv.ac.uk/neuroscience/sanad (accessed Mar 16, 2006)
110. Tomson T., Perucca E., and Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 45 (2004) 1171-1175
111. Hauser W., and Lee J. Do seizures beget seizures?. Prog Brain Res 135 (2002) 215-219
112. Panayiotopoulos C., Benbadis S., Covanis A., et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 64 (2005) 172-174
113. Perucca E. NICE guidance on newer drugs for epilepsy in adults. BMJ 328 (2004) 1273-1274
114. Brodie M. Medical therapy of epilepsy: when to initiate treatment and when to combine?. J Neurol 252 (2005) 125-130
115. Pisani F., Oteri G., Russo M., et al. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40 (1999) 1141-1146
116. Bialer M., Johannessen S., Kupferberg H., et al. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res 61 (2004) 1-48
117. Benbadis S., Tatum W., and Gieron M. Idiopathic generalized epilepsy and choice of antiepileptic drugs. Neurology 61 (2003) 1793-1795
118. Perucca E., Gram L., Avanzini G., et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39 (1998) 5-17
119. Hirsch E., and Genton P. Antiepileptic drug-induced pharmacodynamic aggravation of seizures: does valproate have a lower potential?. CNS Drugs 17 (2003) 633-640
120. Chaves J., and Sander J. Seizure aggravation in idiopathic generalised epilepsies. Epilepsia 46 suppl 9 (2005) 133-139
121. Vestergaard P., Rejnmark L., and Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 45 (2004) 1330-1337
122. Ensrud K., Walczak T., Blackwell T., et al. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62 (2004) 2051-2057
123. Ecevit C., Aydogan A., Kavakli T., et al. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 31 (2004) 279-282
124. Pack A., Morrell M., Marcus R., et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 57 (2005) 252-257
125. Vajda F., Lander C., O'Brien T., et al. Australian pregnancy registry of women taking antiepileptic drugs. Epilepsia 45 (2004) 1466
126. Holmes L., Wyszynski D., and Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61 (2004) 673-678
127. Wide K., Winbladh B., and Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93 (2004) 174-176
128. Russell A., Craig J., Morrison P., et al. UK epilepsy and pregnancy group. Epilepsia 45 (2004) 1467
129. Holmes L., and Wyszynski D. North American antiepileptic drug pregnancy registry. Epilepsia 45 (2004) 1465
130. Artama M., Auvinen A., Raudaskoski T., et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64 (2005) 1874-1878
131. Wyszynski D., Nambisan M., Surve T., et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64 (2005) 961-965
132. Cunnington M., and Tennis P. Lamotrigine and the risk of malformations in pregnancy. Neurology 64 (2005) 955-960
133. Adab N., Kini U., Vinten J., et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75 (2004) 1575-1583
134. Vinten J., Adab N., Kini U., et al. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64 (2005) 949-954
135. Nicolson A., Appleton R., Chadwick D., et al. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry 75 (2004) 75-79
136. Patsalos P., and Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2 (2003) 347-356
137. Sabers A., Ohman I., Christensen J., et al. Oral contraceptives reduce lamotrigine plasma levels. Neurology 61 (2003) 570-571
138. Tate S., Depondt C., Sisodiya S., et al. Genetic predictors of the maximum doses patients receive during clinical use of the antiepileptic drugs carbamazepine and phenytoin. Proc Natl Acad Sci USA 102 (2005) 5507-5512
139. Schmidt D., and Loscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46 (2005) 858-877
140. Remy S., Gabriel S., Urban B., et al. A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53 (2003) 469-479
141. Siddiqui A., Kerb R., Weale M., et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348 (2003) 1442-1448
142. Tan N., Heron S., Scheffer I., et al. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63 (2004) 1090-1092
143. Kwan P., and Brodie M. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
144. Picot M., Neveu D., Kahane P., et al. Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy-preliminary results. Rev Neurol (Paris) 160 (2004) 5S354-5S367
145. Wiebe S., Blume W., Girvin J., et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345 (2001) 311-318
146. McIntosh A., Kalnins R., Mitchell L., et al. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain 127 (2004) 2018-2030
147. Wiebe S., Matijevic S., Eliasziw M., et al. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 73 (2002) 116-120
148. Thadani V., Siegel A., Lewis P., et al. Validation of ictal single photon emission computed tomography with depth encephalography and epilepsy surgery. Neurosurg Rev 27 (2004) 27-33
149. FineSmith R., Zampella E., and Devinsky O. Vagal nerve stimulator: a new approach to medically refractory epilepsy. N J Med 96 (1999) 37-40
150. Theodore W., and Fisher R. Brain stimulation for epilepsy. Lancet Neurol 3 (2004) 111-118
151. Lhatoo S., Solomon J., McEvoy A., et al. A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom. Epilepsia 44 (2003) 673-676
152. Aschenbrenner-Scheibe R., Maiwald T., Winterhalder M., et al. How well can epileptic seizures be predicted? An evaluation of a nonlinear method. Brain 126 (2003) 2616-2626
153. Jouny C., Franaszczuk P., and Bergey G. Signal complexity and synchrony of epileptic seizures: is there an identifiable preictal period?. Clin Neurophysiol 116 (2005) 552-558
154. Mormann F., Kreuz T., Rieke C., et al. On the predictability of epileptic seizures. Clin Neurophysiol 116 (2005) 569-587
155. Nilsen K., and Cock H. Focal treatment for refractory epilepsy: hope for the future?. Brain Res Brain Res Rev 44 (2004) 141-153
156. Stein A., Eder H., Blum D., et al. An automated drug delivery system for focal epilepsy. Epilepsy Res 39 (2000) 103-114